Lecoffre C - Search Results

1

[The practitioner's role in surveillance and information on environmental risks].

Ledrans M, Bretin P, Gourier-Fréry C, Lecoffre C, Le Moal J, Salines G. Ledrans M, et al. Among authors: lecoffre c. Rev Prat. 2005 Nov 30;55(18):2016-25. Rev Prat. 2005. PMID: 16419906 French.

2

Blood lead levels and risk factors in young children in France, 2008-2009.

Etchevers A, Bretin P, Lecoffre C, Bidondo ML, Le Strat Y, Glorennec P, Le Tertre A. Etchevers A, et al. Among authors: lecoffre c. Int J Hyg Environ Health. 2014 Apr-May;217(4-5):528-37. doi: 10.1016/j.ijheh.2013.10.002. Epub 2013 Oct 30. Int J Hyg Environ Health. 2014. PMID: 24262290

3

Screening for Elevated Blood Lead Levels in Children: Assessment of Criteria and a Proposal for New Ones in France.

Etchevers A, Glorennec P, Le Strat Y, Lecoffre C, Bretin P, Le Tertre A. Etchevers A, et al. Among authors: lecoffre c. Int J Environ Res Public Health. 2015 Dec 3;12(12):15366-78. doi: 10.3390/ijerph121214989. Int J Environ Res Public Health. 2015. PMID: 26633457 Free PMC article.

4

What is the evolution of stroke unit's accessibility in metropolitan France from 2009 to 2014? A trend analysis of over 600 000 patients using national hospital databases.

Istvan M, Lecoffre C, Bayat S, Béjot Y, Le Strat Y, De Peretti C, Gao F, Olié V, Grimaud O. Istvan M, et al. Among authors: lecoffre c. BMJ Open. 2018 Sep 28;8(9):e023599. doi: 10.1136/bmjopen-2018-023599. BMJ Open. 2018. PMID: 30269075 Free PMC article.

5

National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014.

Lecoffre C, de Peretti C, Gabet A, Grimaud O, Woimant F, Giroud M, Béjot Y, Olié V. Lecoffre C, et al. Stroke. 2017 Nov;48(11):2939-2945. doi: 10.1161/STROKEAHA.117.017640. Epub 2017 Sep 29. Stroke. 2017. PMID: 28970279 Free article.

6

Regional disparities in acute and post-acute care of stroke patients in France, 2015.

de Peretti C, Gabet A, Lecoffre C, Oberlin P, Olié V, Woimant F. de Peretti C, et al. Among authors: lecoffre c. Rev Neurol (Paris). 2018 Sep-Oct;174(7-8):555-563. doi: 10.1016/j.neurol.2017.09.014. Epub 2018 Apr 24. Rev Neurol (Paris). 2018. PMID: 29703444

7

SSR182289A, a novel, orally active thrombin inhibitor: in vitro profile and ex vivo anticoagulant activity.

Berry CN, Lassalle G, Lunven C, Altenburger JM, Guilbert F, Lalé A, Hérault JP, Lecoffre C, Pfersdorff C, Herbert JM, O'Connor SE. Berry CN, et al. Among authors: lecoffre c. J Pharmacol Exp Ther. 2002 Dec;303(3):1189-98. doi: 10.1124/jpet.102.040667. J Pharmacol Exp Ther. 2002. PMID: 12438543

8

Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.

Berry CN, Visconte C, Lecoffre C, Lochot S, Girard D. Berry CN, et al. Among authors: lecoffre c. Thromb Haemost. 2000 Aug;84(2):286-90. Thromb Haemost. 2000. PMID: 10959702

9

Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animals.

Berry CN, Lunven C, Lecoffre C, Lainée P, O'Connor SE, André F, Roger B, Garrigou-Gadenne D, Rouchouse A, Roome NO, Vivan N. Berry CN, et al. Among authors: lecoffre c. Thromb Haemost. 2000 Aug;84(2):278-85. Thromb Haemost. 2000. PMID: 10959701

10

Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.

Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN. Lunven C, et al. Among authors: lecoffre c. Thromb Haemost. 1996 Jan;75(1):154-60. Thromb Haemost. 1996. PMID: 8713795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters